Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Brickell Biotech (BBI) stock

Learn how to easily invest in Brickell Biotech stock.

Brickell Biotech, Inc
NASDAQ: BBI - USD
BIOTECHNOLOGY
$0.68
+$0.05 (+7.97%)

Brickell Biotech, Inc is a biotechnology business based in the US. Brickell Biotech shares (BBI) are listed on the NASDAQ and all prices are listed in US Dollars. Brickell Biotech employs 13 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Brickell Biotech

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BBI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Brickell Biotech stock price (NASDAQ: BBI)

Use our graph to track the performance of BBI stocks over time.

Brickell Biotech shares at a glance

Information last updated 2021-07-23.
Latest market close$0.82
52-week range$0.47 - $1.70
50-day moving average $0.85
200-day moving average $1.04
Wall St. target price$5.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-9.55

Buy Brickell Biotech shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Brickell Biotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Brickell Biotech price performance over time

Historical closes compared with the close of $0.82 from 2021-05-28

1 week (2021-07-17) N/A
1 month (2021-06-28) -11.83%
3 months (2021-04-28) -24.07%
6 months (2021-01-24) N/A
1 year (2020-07-24) N/A
2 years (2019-07-24) N/A
3 years (2018-07-24) N/A
5 years (2016-07-24) N/A

Brickell Biotech financials

Revenue TTM $793,000
Gross profit TTM $-9,394,000
Return on assets TTM -62.34%
Return on equity TTM -147.35%
Profit margin 0%
Book value $0.43
Market capitalisation $47.5 million

TTM: trailing 12 months

Shorting Brickell Biotech shares

There are currently 4.2 million Brickell Biotech shares held short by investors – that's known as Brickell Biotech's "short interest". This figure is 3.9% up from 4.1 million last month.

There are a few different ways that this level of interest in shorting Brickell Biotech shares can be evaluated.

Brickell Biotech's "short interest ratio" (SIR)

Brickell Biotech's "short interest ratio" (SIR) is the quantity of Brickell Biotech shares currently shorted divided by the average quantity of Brickell Biotech shares traded daily (recently around 1.5 million). Brickell Biotech's SIR currently stands at 2.79. In other words for every 100,000 Brickell Biotech shares traded daily on the market, roughly 2790 shares are currently held short.

However Brickell Biotech's short interest can also be evaluated against the total number of Brickell Biotech shares, or, against the total number of tradable Brickell Biotech shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Brickell Biotech's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Brickell Biotech shares in existence, roughly 60 shares are currently held short) or 0.0641% of the tradable shares (for every 100,000 tradable Brickell Biotech shares, roughly 64 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Brickell Biotech.

Find out more about how you can short Brickell Biotech stock.

Brickell Biotech share dividends

We're not expecting Brickell Biotech to pay a dividend over the next 12 months.

Have Brickell Biotech's shares ever split?

Brickell Biotech's shares were split on a 1:7 basis on 2 September 2019. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Brickell Biotech shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Brickell Biotech shares which in turn could have impacted Brickell Biotech's share price.

Brickell Biotech overview

Brickell Biotech, Inc. , a clinical-stage pharmaceutical company, focuses on identifying, developing, and commercializing various prescription therapeutics for the treatment of debilitating skin diseases in the United States. The company's lead product candidate is sofpironium bromide that is in phase 3 clinical trial to treat patients with primary axillary hyperhidrosis. It has a collaboration agreement with AnGes, Inc. for the development of a novel DNA vaccine candidate for COVID-19. The company was founded in 2009 and is headquartered in Boulder, Colorado. .

Stocks similar to Brickell Biotech

Frequently asked questions

What percentage of Brickell Biotech is owned by insiders or institutions?
Currently 1.478% of Brickell Biotech shares are held by insiders and 10.181% by institutions.
How many people work for Brickell Biotech?
Latest data suggests 13 work at Brickell Biotech.
When does the fiscal year end for Brickell Biotech?
Brickell Biotech's fiscal year ends in December.
Where is Brickell Biotech based?
Brickell Biotech's address is: 5777 Central Avenue, Boulder, CO, United States, 80301
What is Brickell Biotech's ISIN number?
Brickell Biotech's international securities identification number is: US10802T1051
What is Brickell Biotech's CUSIP number?
Brickell Biotech's Committee on Uniform Securities Identification Procedures number is: 10802T105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site